Review of biologics, biosimilars, and intended copies in rheumatology, and current practice in Iraq

Biologic therapies are an important option in the treatment of patients with rheumatic disease. As the development of potential biosimilars increases, many countries are following the guidelines developed by the WHO, European Medicines Agency, or US Food and Drug Administration to create country-spe...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Open Access Rheumatol
Prif Awduron: Al Ani, Nizar Abdulateef, Gorial, Faiq I, Al-Sulaitti, Saad, Humadi, Jasmine Abbas, Awadh, Nabaa Ihsan, Mounir, Mohamed, Dershaby, Yasser El, Jones, Heather, Sunna, Nancy
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove Medical Press 2018
Pynciau:
Review
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6307490/
https://ncbi.nlm.nih.gov/pubmed/30613169
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OARRR.S176965
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg